Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae (Q43912948)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in April 2002

Language	Label	Description	Also known as
English	Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae	scientific article published in April 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

vasoconstriction

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

object named as

Demian F Obregon

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Daniel Paris

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Kirk P Townsend

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

James Humphrey

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Kiyoko Yokota

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

161

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

293-299

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

The Alzheimer diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Brain microvascular changes in Alzheimer's disease and other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Microvascular pathology and vascular basement membrane components in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

The role of cerebral ischemia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Preclinical prediction of Alzheimer's disease using SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Native Nicotinic Acetylcholine Receptors in Human Imr32 Neuroblastoma Cells: Functional, Immunological and Pharmacological Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Intraneuronal beta-amyloid immunoreactivity in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, trk, and morphological differentiation with fatal outcome in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900660-8

7 January 2021

Identifiers

10.1016/S0021-9150(01)00660-8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43912948&oldid=2104354470"